What is Generate Biomedicines, Inc. 's debt-to-equity?

Generate Biomedicines, Inc. (GENB) reported debt-to-equity of 0.1× in Q1 2026.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Generate Biomedicines, Inc. GENB Debt-to-equity

Debt-to-equity at other companies

RepligenRGEN

0.3×+0.2×

Piper SandlerPIPR

0.1×0.0×

MYR GroupMYRG

0.2×0.0×

CHE

ChemedCHE

0.3×+0.2×

American Healthcare REITAHR

0.3×-0.3×

LKQLKQ

0.2×0.0×

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Current ratio9.2×—

Where this comes from

Calculated from Generate Biomedicines, Inc. ’s reported figures.

total debt/total stockholders equity=0.1×

Based on the most recent quarter.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's debt-to-equity?: Generate Biomedicines, Inc. (GENB) reported debt-to-equity of 0.1× in Q1 2026.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.